Article Details

Infinity Pharmaceuticals (NASDAQ:INFI) Stock Rating Upgraded by ValuEngine

Retrieved on: 2019-08-01 19:15:00

Tags for this article:

Click the tags to see associated articles and topics

Infinity Pharmaceuticals (NASDAQ:INFI) Stock Rating Upgraded by ValuEngine. View article details on hiswai:

Excerpt

<div><b>Two Sigma Investments</b> LP now owns 91,296 shares of the biotechnology company's stock worth $108,000 after buying an additional 20,721 shares ...</div>

Article found on:

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up